Log in to save to my catalogue

Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2426532137

Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

About this item

Full title

Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

Publisher

United States: Public Library of Science

Journal title

PloS one, 2020-07, Vol.15 (7), p.e0235990

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Alcoholic steatohepatitis (ASH)-the inflammation of fatty liver-is caused by chronic alcohol consumption and represents one of the leading chronic liver diseases in Western Countries. ASH can lead to organ dysfunction or progress to hepatocellular carcinoma (HCC). Long-term alcohol abstinence reduces this probability and is the prerequisite for liv...

Alternative Titles

Full title

Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2426532137

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2426532137

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0235990

How to access this item